05.10.2023 CompuGroup Medical SE & Co. KGaA  DE000A288904

EQS-News: CompuGroup Medical bundles data-based solutions with ambulatory information systems and appoints Daniela Hommel as CFO


 

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel
CompuGroup Medical bundles data-based solutions with ambulatory information systems and appoints Daniela Hommel as CFO

05.10.2023 / 08:25 CET/CEST
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical bundles data-based solutions with ambulatory information systems and appoints Daniela Hommel as CFO

 

  • CGM integrates business activities of the CHS segment into the AIS segment
  • Managing Director Consumer Health Management Information Systems Dr. Eckart Pech leaves CGM at his own request at the end of March 2024 after successfully building-up the data business
  • Administrative Board appoints Daniela Hommel as Chief Financial Officer effective March 2024


CompuGroup Medical SE & Co. KGaA (CGM), one of the world's leading e-health providers, continues to drive forward the customer focus of its digital solutions and the use of Artificial Intelligence (AI). Core activities are bundled especially for CGM customers in order to drive digitization in healthcare even faster. Studies show that for every hour doctors and their teams can devote to patients, they spend three to four hours on administrative work. AI-based solutions can significantly reduce such inefficiencies in healthcare for the benefit of patients. In order to provide the best possible support for customers, the business activities in the CHS segment will be integrated in the AIS segment going forward.

Dr. Eckart Pech, Managing Director Consumer & Health Management Information Systems, is leaving the company at his own request as of March 2024 after the successful build-up phase of the data business. Since joining the company in November 2019, Eckart Pech had initially driven the expansion of the telematics infrastructure in Germany. With the increasing relevance of data usage to support physicians, he was responsible for the establishment and successful expansion of the data business.

Also effective as of March 2024, the Board of Directors appoints Daniela Hommel as Chief Financial Officer. Daniela Hommel has held various finance and controlling positions in the Fresenius Group since 2012. Since 2018 she was responsible for the performance of the Fresenius Helios segment as Chief Financial Officer. In 2022, she assumed the role of Chief Financial and Innovation Officer of Helios Global Health GmbH with the aim of improving access to healthcare worldwide with new forms of care. In addition, she has assumed business responsibility for Fresenius' digital daughter Curalie as CEO since 2022. Prior to that, she spent 14 years at KPMG, most recently as the responsible audit partner in the healthcare sector. Until she joins CompuGroup Medical, CEO Michael Rauch will continue to be responsible for the CFO role on an interim basis.

Frank Gotthardt, founder of CGM and Chairman of the Board of Directors, commented, "CGM remains a driver of digitization in healthcare, both nationally and internationally. Data-based solutions and artificial intelligence will play a decisive role in the future. With Daniela Hommel, we are gaining an excellent financial expert with experience in the healthcare sector. I would like to expressly thank Eckart Pech for his important contributions to CGM's success, especially in building data-based solutions. We wish him all the best for the future."

Michael Rauch adds: "While integrating the CHS business activities into the AIS segment, the focus is on the added value for physicians, whom we support in the digitization of healthcare. I look forward to working with Daniela Hommel, thank Eckart Pech for the excellent collaboration over the past four years and wish him all the best as well."


About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.130 billion in 2022, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals and social welfare institutions. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 21 countries and products in 60 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 9,200 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.



05.10.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1741763

 
End of News EQS News Service

1741763  05.10.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1741763&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023
Umsatzerlöse1 582,38 717,02 745,81 837,26 1.025,32 1.129,74 1.187,66
EBITDA1,2 128,44 187,84 178,13 197,48 213,39 216,35 229,76
EBITDA-Marge3 22,05 26,20 23,88 23,59 20,81 19,15
EBIT1,4 90,07 143,23 115,27 121,77 102,68 104,03 98,00
EBIT-Marge5 15,47 19,98 15,46 14,54 10,01 9,21 8,25
Jahresüberschuss1 31,74 96,34 66,15 73,42 69,03 74,12 46,87
Netto-Marge6 5,45 13,44 8,87 8,77 6,73 6,56 3,95
Cashflow1,7 85,82 136,35 110,50 149,93 165,27 145,03 179,53
Ergebnis je Aktie8 0,63 1,92 1,33 1,40 1,30 1,40 0,88
Dividende8 0,35 0,50 0,50 0,50 0,50 0,50 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
CompuGroup Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A28890 14,000 Halten 752,28
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
11,97 34,38 0,35 12,02
KBV KCV KUV EV/EBITDA
1,29 4,19 0,63 6,23
Dividende '22 in € Dividende '23 in € Div.-Rendite '23
in %
Hauptversammlung
0,50 1,00 7,14 14.05.2025
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
30.04.2025 31.07.2025 07.11.2024 06.03.2025
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-0,45% -35,18% -63,06% -62,18%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu CompuGroup Medical SE & Co. KGaA  ISIN: DE000A288904 können Sie bei EQS abrufen


Software , A28890 , COP , XETR:COP